Newsletter sign up


ADC University Our services

ADC Review
is made possible by:



Copyright 2017
Terms & Conditions


Call for Papers

Researchers and Scientists interested in publishing their work related to the development of Antibody-drug Conjugates should consider ADC Review / Journal of Antibody-drug Conjugates.

ADC Review / Journal of Antibody-drug Conjugates is an international, open access, peer-reviewed journal and publishing platform for the presentation of new advances and research results. The journal provides rapid publication options for original, unpublished research and review articles as well as editorials and short communications related to ADCs.

The Journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence.


ADC_CallForPapers_Ad_468x60_v1


Peer review
All manuscripts submitted are peer-reviewed. The review process will be completed within two weeks following submission. The manuscripts will be published online shortly after acceptance and the article proof will be mailed to the corresponding author.

The rapid development of targeted therapies, including Antibody-drug Conjugates as well as the complexity for practicing oncologists and hematologists to implement novel approaches in their clinical practice offers unique challenges.

A better understanding of ADCs
ADC Review / Journal of Antibody-drug Conjugates aims to provide a better understanding of ADCs as well as practical suggestions to implement novel approaches in targeted therapies

For more information and/or immediate consideration, please send a cover letter, manuscripy, complete with references, graphs and artwork to the editor (editor@inpressmediagroup.com).

The editors are pleased to consider manuscripts on a wide range of topics related to our mission. Articles may include:

  • Original research
  • Reviews
  • Editorials and perspectives
  • Clinical case reports
  • State-of-the-Art/(New)Technology Updates
  • Guidelines

ADC_CallForPapers_Ad_468x60_v1


ADC Review / Journal of Antibody-drug Conjugates is an open access peer reviewed journal of which published content is focusing entirely on Antibody-drug Conjugates and related therapies. By publishing open access, you can take full advantage of the features of our journal, including:

  • High visibility for your work – anyone can read you article without charge or any other barrier to access
  • Convenient online manuscript submission (via our submission site)
  • Fast and thorough peer review by our independent review board
  • No space constraints or color figure charges
  • Immediate publication on approval
  • Research which is freely available for redistribution (all published articles are creative commons 3.0 licensed)
  • Updates about the state of submission of your manuscript delivered via email and Text/SMS
  • Compliance with open access mandates, including the NIH Public Access Policy and the Wellcome Trust Open Access Policy
  • International, open access, peer-reviewed journal
  • Original article downloadable as PDF
  • Following publication, a targeted marketing approach of your article

Submission
For more information and/or immediate consideration, please send a cover letter, manuscript, complete with references, graphs and artwork to the editor (editor@inpressmediagroup.com). Alternatively, submit  your manuscript via our submission site.

The editors are pleased to consider manuscripts on a wide range of topics related to our mission. Articles may include:

  • Original research
  • Reviews
  • Editorials and perspectives
  • Clinical case reports
  • State-of-the-Art/(New)Technology Updates
  • Guidelines

Stay up-to-date
The editors also like to invite you to visit the ADC Review / Journal of Antibody-drug Conjugates website where you can read all the articles published in our journal. Stay up to date with peer reviewed articles, editorials and news related to antibody-drug conjugates (ADCs).

For more information on how to submit a manuscript for peer review, please visit our Author Instruction page of contact us via email at info@inpressmediagroup.com.


Last editorial update: March 7, 2015.

Copyright © 2015 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.

Add to Flipboard Magazine.


ADC_CallForPapers_Ad_468x60_v1


 


Manuscript Guidelines & Tips Lonza

Featured Event

Topics to be Covered Introduction To Antibody Conjugates Overview Of Techniques In Quantitative Pharmacology No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development...


Skip to toolbar